Perspectum Ltd. is a game-changing medical equipment manufacturing start-up based in Oxford, England, that is revolutionizing the field of precision health technology. With their cutting-edge technology, they offer a fuller picture of a patient's health status, going beyond the incomplete, one-dimensional insights of conventional diagnostics. Perspectum's noninvasive and intuitive approach to extracting biomarkers from imaging can lead to better diagnoses and outcomes, aiding clinical decision-making and patient engagement. 

Founded by Rajarshi Banerjee in partnership with the University of Oxford in 2012, the company has since blossomed into a major player in the field of digital medical technology and diagnostics, with a focus on liver and bile diseases, long COVID, diabetes, and cancer. With a recent Series C funding of $36M from Oppenheimer & Co. Inc., Perspectum's diverse and talented team is united behind their vision to build a better tomorrow for patients through scientific innovation. By enabling early detection, diagnosis, and targeted treatment, Perspectum is empowering patients and clinicians to better understand chronic systemic diseases.